News

AddToAny

Google+ Facebook Twitter Twitter

Second person to be clear of HIV

A UK patient’s HIV has become “undetectable” following a stem cell transplant – in the second case of its kind.

HIV Shutterstock

The London patient, who was being treated for cancer, has now been in remission from HIV for 18 months and is no longer taking HIV drugs. However, the researchers stressed it is too early to say the patient is “cured” of HIV.

Experts said the approach is not practical for treating most people with HIV, but may one day help find a cure.

The unnamed patient was diagnosed with HIV in 2003 and advanced Hodgkin’s lymphoma in 2012.

He had chemotherapy to treat the Hodgkin’s cancer and stem cells were implanted into the patient from a donor resistant to HIV, leading to both his cancer and HIV going into remission.

Researchers from University College London, Imperial College London, Cambridge and Oxford universities were all involved in the case.

go.nature.com/2CchEKT

 

Image credit | Shutterstock

Related Articles

CRISPR-Cas9 gene editing complex, illustration.Image credit - Science-Photo-Library-f0248864

Activating genes using CRISPR technology

There are over 7000 different rare genetic diseases, and often it can be a significant challenge and take a long time to receive a correct diagnosis.

Blue helix human DNA structure-Image credit-shutterstock-1669326868

The search for genes that cause diseases

A new statistical tool developed by researchers at the University of Chicago improves the ability to find genetic variants that cause disease.

pathogenspreadhr-CREDIT-spooky-pooka

Figuring out the threats: Problem-solving with genomics

As the COVID-19 enquiry continues to unpick the tangled threads of the pandemic response, little has been said about one of the most effective weapons against the SARS-Cov-2 virus – pathogen genomics.

breast cancer cells - CREDIT - Science Photo Library-c0559159

Breast cancer cells’ self-sacrifice is potential cause of relapse

For patients with early-stage breast cancer, there is a 7% to 11% chance of relapse within five years after receiving initial treatment.

Top